Nebiye YENTÜR DONİ, Gülcan GÜRSES, Zeynep ŞİMŞEK, Fadile YILDIZ ZEYREK, Muhsin AKBABA

The knowledge and high seroprevalence of hepatitis A in a high-risk group (agricultural reproductive-aged women) in the southeastern region of Turkey

Background/aim: The aim of this study was to determine the seroprevalence of antihepatitis A virus (HAV), risk factors, and the knowledge of female farm workers living in the Southeastern Anatolia Region (SAR) of Turkey. Materials and methods: This representative cross-sectional survey was conducted between January and April of 2013 in the SAR. A total of 705 reproductive-aged women were randomly selected by clustering method using Epi Info software. The sera were analyzed for anti-HAV antibodies using ELISA. Sociodemographic information and the knowledge of female farm workers regarding hepatitis A were collected using a questionnaire. Results: Of the female farm workers, 99.1% were seropositive for anti-HAV. The anti-HAV seroprevalence was significantly higher in the adults than in the adolescents (P < 0.05). Of the participants, 64.5% had 7 or more family members, 58.4% had 5 or more pregnancies, 68.1% were illiterate, 65.2% were family farmers, 90.6% were poor, 71.9% used unsafe water, 58.9% had toilets outside, and 68% had no knowledge about hepatitis A. Conclusion: Turkey is considered to have high endemicity and female farm workers are considered a high-risk group for hepatitis A. This high HAV exposure might be reduced with vaccination, as well as improvements in sanitation, living conditions, health care utilization, safer drinking water, and health education.

PDF

___

1. WHO. Hepatitis A 2014. Available from: http://www.who.int/ mediacentre/factsheets/fs328/en/.
2. Jacobsen KH. The Global Prevalence of Hepatitis A Virus Infection and Susceptibility: A Systematic Review. CH-1211 Geneva 27, Switzerland: WHO Document Production Services; 2009.
3. Kurugöl Z, Koturoğlu G, Akşit S, Özacar T. Seroprevalence of hepatitis A infection in the Turkish Republic of Northern Cyprus. Turk J Med Sci 2009; 39: 109-113.
4. Mistik R, Balik I. Türkiyede viral hepatitlerin epidemiyolojik analizi. In: Balik İ, Tekeli E, editors. Viral Hepatit. Ankara: The Organization of War with Viral Hepatitis; 2002. pp. 3-35.
5. Tosun S, Ertan P, Kasirga E, Atman U. Changes in seroprevalence of hepatitis A in children and adolescents in Manisa, Turkey. Pediatr Int 2004; 46: 669-672.
6. MOH. 2012 annual report of Turkish Ministry of Health. Childhood vaccination schedule Ankara: Republic of Turkey, Ministry of Health Publication 2013. Available from: http://thsk. saglik.gov.tr/dosya/faaliyet_raporu/2012_faaliyet_raporu.pdf.
7. ILO. Agriculture; plantations; other rural sectors 2013. Available from: http://www.ilo.org/global/industries-and-sectors/ agriculture-plantations-other-rural-sectors/lang--en/index. htm.
8. TSI. Address Based Population Registration System Results. Publications of Turkish Statitical Institue: Turkish Statitical Institue; 2012. Available from: http://www.turkstat.gov.tr/Start. do.
9. GAP. Objectives of GAP 2013. Available from: http://www.gap. gov.tr/about-gap/objectives-of-gap.
10. Simsek Z. GAP tarımda çalışanların sağlğı araştırması. Şanlıurfa: Harran Üniversitesi Tarıimda İs Sağlığıve Güvenliği Uygulama ve Araştırrma Merkezi; 2013.
11. HAVAb IgG Architect System. Wiesbaden, Germany: Abbott Diagnostic Division, 2004.
12. Bell BP, Wasley A, Feinstone SM. Hepatitis A virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA, USA: Churchill Livingstone; 2010. pp. 2367-2387.
13. Antaki N, Kebbewar MK. Hepatitis A seroprevalence rate in Syria. Trop Doct 2000; 30: 99-101.
14. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, Adibi P. HAV in Isfahan province: a populationbased study. Trop Gastroenterol 2008; 29: 160-162.
15. Turky AM, Akram W, Al-Naaimi AS, Omer AR, Rasheed AlRawi J. Analysis of acute viral hepatitis (A and E) in Iraq. Glob J Health Sci 2011; 3: 70-76.
16. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, Naghoosi H, Karayiannis P, Zali MR. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. T Roy SocTrop Med H 2012; 106: 528-531.
17. Aygen B. Hepatit A Virusu. In: Willke Topçu A, Söyletir G, Doğanay M, editors. Infeksiyon Hastalıkları ve Mikrobiyolojisi Cilt II. İstanbul, Turkey: Nobel Tıp Kitabevleri; 2008. pp. 1871- 1882.
18. Aslan G, Seyrek A, İşcan A, Sevinç E, Ulukanlıgil M, Bakır M. Şanlıurfada Hepatit A Seroprevalansı. Viral Hepatit Dergisi 2001; 7 (in Turkish with English abstract).
19. Ceran N, Yuksel Kocdogan F, Mert D, Erdem I, Dede B, Adaleti R, Ozyurek S, Karagül E, Goktas P. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat 2012; 19: 72-76.
20. Cesur S, Akin K, Dogaroglu I, Birengel S, Balik I. Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area. Mikrobiyol Bul 2002; 36: 79-83 (in Turkish with English abstract).
21. Erturk A, Copur Cicek A, Cure E, Akdogan AR, Ozturk C. Seroprevalence of hepatitis A in Rize Province and different adult age groups. Viral Hepatit Dergisi 2013; 19: 85-88 (in Turkish with English abstract).
22 Tosun S, Yildiz O, Tekinkoruk S, Celen MK, Yilmaz G, Karabay O. Kronik HBV ve HCV Olgularının HAV ile Karşılaşma Durumlarını Yeterince Değerlendiriyor muyuz? XI Ulusal Viral Hepatit Kongresi; 12-13 April 2012; Antalya, Turkey. p. 80-81.
23. Kanra G, Tezcan S, Badur S, Turkish National Study T. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002; 44: 204-210.
24. Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat 2014; 21: 605-615.
25. Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: implications for hepatitis A vaccination. Hum Vaccin Immunother 2013; 9: 375-381.
26. Turker K, Balcı E, Batı S, Hascuhadar M, Savas E. Ülkemizde Hepatit A Enfeksiyonunun Değişen Epidemiyolojisi. Türk Mikrobiyol Cem Derg 2011; 41: 143-148 (in Turkish with English abstract).
27. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132: 1005-1022.
28. Mele A, Stroffolini T, Palumbo F, Gallo G, Ragni P, Balocchini E, Tosti ME, Corona R, Marzolini A, Moiraghi A. Incidence of risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. J Hepatol 1997; 26: 743-747.
29. Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (19821998). J Viral Hepat 2001; 8: 293-303.
30. Alameida LM, Amaku M, Azevedo RS, Cairncross S, Massad E. The intensity of transmission of hepatitis A and heterogeneities in social-environmental risk factors in Rio de Janeiro, Brazil. T Roy SocTrop Med H 2002; 96: 605-610.
31. Kurugol Z, Aslan A, Turkoglu E, Koturoglu G. Changing epidemiology of hepatitis A infection in Izmir, Turkey. Vaccine 2011; 29: 6259-6261.
32. Simsek Z, Koruk İ, Doni Yentür N. An operational study on implementation of mobile primary healthcare services for seasonal migratory farmworkers, Turkey. Matern Child Health J 2012; 16: 1906-1912.